Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

LU 103793

Known as: LU-103793, LU103793 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Novel toxic metabolites from marine cyanobacteria have been thoroughly explored. Biologically active and chemically diverse… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 4
Is this relevant?
2001
2001
LU103793, a synthetic analogue of dolastatin 15, showed interesting pre-clinical activity in melanoma xenografts. In this phase… Expand
Is this relevant?
1999
1999
The linear peptide dolastatin 15 (1), a potent antineoplastic constituent from the shell-less mollusk Dolabella auricularia, has… Expand
Is this relevant?
1998
1998
PURPOSE To determine the maximum-tolerated dose (MTD), dose-limiting toxicities (DLTs), and pharmacokinetic profile of the… Expand
Is this relevant?
1998
1998
Cemadotin (LU103793) (NSC D-669356) is a water-soluble synthetic analogue of dolastatin 15 that inhibits cell proliferation in… Expand
Is this relevant?
1996
1996
Background: To study the toxicity and pharmacokinetics of LU103793 (Cematodin®), a novel cytotoxic anticancer drug being an… Expand
Is this relevant?
1995
1995
LU103793 (NSC D-669356) is a new synthetic derivative of Dolastatin 15, an antiproliferative compound which was isolated from the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?